Modeling the cost and impact of injectable opioid agonist therapy on overdose and overdose deaths

An implementation scenario with greater unsupervised iOAT compared to supervised iOAT allows for an increased reduction in overdose and overdose deaths per annum at the same cost, with the additional benefit of increased treatment coverage among people who inject opioids.